Eric R. Olson's Insider Trades & SAST Disclosures

Eric R. Olson's most recent trade in Syros Pharmaceuticals Inc. was a trade of 689 Common Stock done at an average price of $3.5 . Disclosure was reported to the exchange on July 17, 2023.

Share

Note

This is a custom search result for pattern Eric R. Olson.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.

All Superstars

"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches "Balanced Fund" but not "Balanced Growth Fund" Balanced Fund: Use this format without quotation marks to search for all funds related to the term "Balanced Fund" The results may include "Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".

Stock	Client Name	Client Category	Action	Reported to Exchange	Quantity	Post Transaction Holding	Traded %	Avg. Price	Value	Security Type
Syros Pharmaceuticals Inc. Results Board Meeting	Eric R. Olson	Chief Scientific Officer	Sale of securities on an exchange or to another person at price $ 3.50 per share.	17 Jul 2023	689	6,661 (0%)	0%	3.5	2,412	Common Stock
Syros Pharmaceuticals Inc. Results Board Meeting	Eric R. Olson	Chief Scientific Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	31 Mar 2023	2,000	7,973 (0%)	0%		-	Common Stock
Syros Pharmaceuticals Inc. Results Board Meeting	Eric R. Olson	Chief Scientific Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	31 Mar 2023	2,000	6,000	-		-	Restricted Stock Units
Syros Pharmaceuticals Inc. Results Board Meeting	Eric R. Olson	Chief Scientific Officer	Payment of exercise price or tax liability using portion of securities received from the company at price $ 2.58 per share.	31 Mar 2023	623	7,350 (0%)	0%	2.6	1,607	Common Stock
Syros Pharmaceuticals Inc. Results Board Meeting	Eric R. Olson	Chief Scientific Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	16 Feb 2023	35,000	35,000	-		-	Restricted Stock Units
Syros Pharmaceuticals Inc. Results Board Meeting	Eric R. Olson	Chief Scientific Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	06 Oct 2022	44,500	44,500	-		-	Stock Option (right to buy)
Syros Pharmaceuticals Inc. Results Board Meeting	Eric R. Olson	Chief Scientific Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	06 Oct 2022	34,000	34,000	-		-	Restricted Stock Units
Syros Pharmaceuticals Inc. Results Board Meeting	Eric R. Olson	Chief Scientific Officer	Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.12 per share.	01 Apr 2022	27,266	59,734 (0%)	0%	1.1	30,538	Common Stock
Syros Pharmaceuticals Inc. Results Board Meeting	Eric R. Olson	Chief Scientific Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	15 Feb 2022	200,000	200,000	-		-	Restricted Stock Units
Syros Pharmaceuticals Inc. Results Board Meeting	Eric R. Olson	Chief Scientific Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	15 Feb 2022	100,000	100,000	-		-	Stock Option (right to buy)
Syros Pharmaceuticals Inc. Results Board Meeting	Eric R. Olson	Chief Scientific Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	15 Feb 2022	80,000	80,000	-		-	Restricted Stock Units
Syros Pharmaceuticals Inc. Results Board Meeting	Eric R. Olson	Chief Scientific Officer	Sale of securities on an exchange or to another person at price $ 3.47 per share.	05 Jan 2022	2,208	0 (0%)	0%	3.5	7,655	Common Stock
Syros Pharmaceuticals Inc. Results Board Meeting	Eric R. Olson	Chief Scientific Officer	Sale of securities on an exchange or to another person at price $ 5.55 per share.	01 Jul 2021	1,164	0 (0%)	0%	5.5	6,460	Common Stock
Syros Pharmaceuticals Inc. Results Board Meeting	Eric R. Olson	Chief Scientific Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.01 per share.	15 Mar 2021	3,628	3,628 (0%)	0%	1.0	3,664	Common Stock
Syros Pharmaceuticals Inc. Results Board Meeting	Eric R. Olson	Chief Scientific Officer	Sale of securities on an exchange or to another person at price $ 9.47 per share.	15 Mar 2021	3,628	0 (0%)	0%	9.5	34,372	Common Stock
Syros Pharmaceuticals Inc. Results Board Meeting	Eric R. Olson	Chief Scientific Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	15 Mar 2021	3,628	90,697	-		-	Stock Option (right to buy)
Syros Pharmaceuticals Inc. Results Board Meeting	Eric R. Olson	Chief Scientific Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	17 Feb 2021	94,000	94,000	-		-	Stock Option (right to buy)

*All Values are in $ Million

Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures

Data as reported to USA Exchanges

View All The Insider Trades